Will HIV Sales Drive Gilead (GILD) to Beat in Q2 Earnings?

Will HIV Sales Drive Gilead (GILD) to Beat in Q2 Earnings?

Source: 
Yahoo/Zacks.com
snippet: 

Biotech bigwig Gilead Sciences Inc. GILD is likely to beat expectations when it reports results for the second quarter on Jul 25, after the market closes.